Home / Inspections / 1233729

FDA Inspection 1233729 — Reproductive Gynecology Labs Columbus

Reproductive Gynecology Labs Columbus — FEI 3008808150

The FDA completed an inspection of Reproductive Gynecology Labs Columbus on March 11, 2024 in Westerville, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Westerville, OH (United States)

Facility

Other inspections at this facility

  • 1153901 (NAI Wed Sep 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1039094 (NAI Thu Jan 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983438 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 893016 (NAI Fri Aug 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 779301 (NAI Fri May 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources